PHILADELPHIA–(BUSINESS WIRE)–The Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund) today announced its investment in Emvena Therapeutics, a biotechnology company developing mRNA medicines designed to deliver treatments directly to the placenta to address serious maternal and fetal conditions. Emvena is the first company launched and financed by the PxB Fund, which supports the translation of promising University of Pennsylvania research for the advancement of human health. Emvena’s l
